The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells
Open accessAbstract
Abstract —Oxidized low density lipoprotein (Ox-LDL) induces apoptosis in vascular smooth muscle cells (VSMCs), which may increase atherosclerotic plaque instability. In this study, we examined the molecular mechanisms causing the Ox-LDL–induced apoptosis in VSMCs, especially focusing on the involvement of Bax/Bcl-2 and the lectinlike Ox-LDL receptor-1 (LOX-1). In cultured bovine aortic smooth muscle cells (BASMCs), Ox-LDL at high concentrations (>60 μg/mL) induced cell death as demonstrated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. DNA fragmentation was increased in BASMCs treated with high concentrations of Ox-LDL, indicating that the Ox-LDL–induced cell death in VSMCs was apoptosis. Ox-LDL upregulated LOX-1 expression through phosphorylation of extracellular signal–regulated kinase in BASMCs, and a neutralizing anti–LOX-1 monoclonal antibody, which can block LOX-1–mediated cellular uptake of Ox-LDL, prevented the Ox-LDL–induced apoptosis in BASMCs. This antibody also suppressed the increase in the Bax to Bcl-2 ratio induced by Ox-LDL in BASMCs. Furthermore, LOX-1 expression was well colocalized with Bax expression in the rupture-prone shoulder areas of human atherosclerotic plaques in vivo. LOX-1 may play an important role in Ox-LDL–induced apoptosis in VSMCs by modulating the Bax to Bcl-2 ratio. These molecular mechanisms may be involved in destabilization and rupture of atherosclerotic plaques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Li, D., & Mehta, J. L. (2000) · Circulation · doi:10.1161/01.cir.101.25.2889 · Cited by 421
Cited by
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
New Markers of Inflammation and Endothelial Cell Activation: Part I
Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738
MEHTA, J., CHEN, J., HERMONAT, P., ROMEO, F., & NOVELLI, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.006 · Cited by 440
Vascular smooth muscle cell in atherosclerosis
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Acta Physiologica · doi:10.1111/apha.12466 · Cited by 384
Metabolism of vascular smooth muscle cells in vascular diseases
Shi, J., Yang, Y., Cheng, A., Xu, G., & He, F. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00220.2020 · Cited by 366
Chen, M., Masaki, T., & Sawamura, T. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00236-x · Cited by 375
Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
Poznyak, A. V., Nikiforov, N. G., Markin, A. M., Kashirskikh, D. A., Myasoedova, V. A., Gerasimova, E. V., & Orekhov, A. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.613780 · Cited by 370
Scavenger Receptor Structure and Function in Health and Disease
Zani, I., Stephen, S., Mughal, N., Russell, D., Homer-Vanniasinkam, S., Wheatcroft, S., & Ponnambalam, S. (2015) · Cells · doi:10.3390/cells4020178 · Cited by 361
Biochemistry and cell biology of mammalian scavenger receptors
Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.036 · Cited by 333
Oxidized low-density lipoprotein-induced apoptosis
Salvayre, R., Auge, N., Benoist, H., & Negre-Salvayre, A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00343-8 · Cited by 330
Role of Ox-LDL and LOX-1 in Atherogenesis
Kattoor, A. J., Kanuri, S. H., & Mehta, J. L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180508100950 · Cited by 330
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
Trpkovic, A., Resanovic, I., Stanimirovic, J., Radak, D., Mousa, S. A., Cenic-Milosevic, D., Jevremovic, D., & Isenovic, E. R. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.992063 · Cited by 321
Motoshima, H., Wu, X., Mahadev, K., & Goldstein, B. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.049 · Cited by 308
Oxidized LDL, LOX-1 and Atherosclerosis
Mitra, S., Goyal, T., & Mehta, J. L. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6341-5 · Cited by 300
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293
Role of Oxidized LDL in Atherosclerosis
KITA, T., KUME, N., MINAMI, M., HAYASHIDA, K., MURAYAMA, T., SANO, H., MORIWAKI, H., KATAOKA, H., NISHI, E., HORIUCHI, H., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03941.x · Cited by 277
Self-citationRole of Caspases in Ox-LDL–Induced Apoptotic Cascade in Human Coronary Artery Endothelial Cells
Chen, J., Mehta, J. L., Haider, N., Zhang, X., Narula, J., & Li, D. (2004) · Circulation Research · doi:10.1161/01.res.0000113782.07824.be · Cited by 272
LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
Kattoor, A. J., Goel, A., & Mehta, J. L. (2019) · Antioxidants · doi:10.3390/antiox8070218 · Cited by 253
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway
Wu, C.-Y., Tang, Z.-H., Jiang, L., Li, X.-F., Jiang, Z.-S., & Liu, L.-S. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1028-6 · Cited by 190
“Some studies have shown that ox-LDL induced human vascular smooth muscle cell apoptosis via a caspase-dependent pathway; Bcl-2 and Bax, important apoptotic proteins, play key roles in this pathway [13].”
Molecular Genetics of Late‐Onset Alzheimer's Disease
Kamboh, M. I. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00110.x · Cited by 170
LIANG, X., XU, Z., YUAN, M., ZHANG, Y., ZHAO, B., WANG, J., ZHANG, A., & LI, G. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2497 · Cited by 99
“The excessive production of oxidized low-density lipoprotein (ox-LDL) in the blood leads to the adequate removal of fats and cholesterol from macrophages, and consequently promotes the formation of multiple atheromatous plaques within the arteries (3).”
Hofmann, A., Brunssen, C., & Morawietz, H. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.10.002 · Cited by 68
Liu, C., Shi, F., Li, W., & Chen, J. (2022) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.25514 · Cited by 11
Metadata
- Authors
- Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Morimoto, M., Hayashida, K., Hashimoto, N., & Kita, T.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-06
- Volume
- 21
- Issue
- 6
- Pages
- 955-960
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2145712428
- Cited by
- 215
- References
- 2
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.